Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.

Sho-ichi Yamagishi; Yuji Ishibashi; Ayako Ojima; Tatsushi Sugiura; Takanori Matsui

首页> 外文期刊>International Journal of Cardiology >Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.

【24h】

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.

机译：利格列汀，一种基于黄嘌呤的二肽基肽酶-4抑制剂，部分地通过抑制黄嘌呤氧化酶的活性来降低2型糖尿病患者的血清尿酸水平。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

High concentrations of pentosidine show the presence and the severity of CAD with high sensitivity.

机译：高浓度的戊糖苷显示CAD的存在和严重程度，并具有较高的敏感性。

著录项

来源
《International Journal of Cardiology》 |2014年第2期|共3页
作者
Sho-ichi Yamagishi; Yuji Ishibashi; Ayako Ojima; Tatsushi Sugiura; Takanori Matsui;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity. [J] . Sho-ichi Yamagishi, Yuji Ishibashi, Ayako Ojima, International Journal of Cardiology . 2014,第2期

机译：利格列汀，一种基于黄嘌呤的二肽基肽酶-4抑制剂，部分地通过抑制黄嘌呤氧化酶的活性来降低2型糖尿病患者的血清尿酸水平。
2. Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria [J] . Cooper Mark E., Perkovic Vlado, Groop Per-Henrik, Journal of hypertension . 2019,第6期

机译：二肽基肽酶-4抑制剂Linaglitin与肾素 - 血管紧张素系统抑制剂在2型糖尿病患者中患有肾蛋白尿患者的血流动力学效应
3. Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels [J] . Iwasaki,M., Hoshian,F., Tsuji,T., Journal of diabetes investigation. . 2012,第5期

机译：预测二肽基肽酶-4抑制剂在2型糖尿病患者中的功效：糖化血红蛋白减少与血清二十碳五烯酸和二十二碳六烯酸水平的关联
4. Sodium-Glucose Cotransporter-2 Inhibitor Immediately Decreases Serum Uric Acid Levels in Type 2 Diabetic Patients [O] . Naro Ohashi, Taro Aoki, Takashi Matsuyama, 2020

机译：钠 - 葡萄糖Cot转储-2抑制剂立即降低2型糖尿病患者的血清尿酸水平
5. Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, ameliorates experimental autoimmune myocarditis by suppressing cathepsin-G activity [O] . Yuka Shiheido-Watanabe, Yasuhiro Maejima, Shun Nakagama, 2020

机译：基于黄嘌呤的二肽基肽酶-4抑制剂Linaglittin，通过抑制组织蛋白酶-G活性改善实验性自身免疫心肌炎

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor, decreases serum uric acid levels in type 2 diabetic patients partly by suppressing xanthine oxidase activity.

摘要

著录项

相似文献

相关主题

期刊订阅